U.S. markets closed

Citius Pharmaceuticals, Inc. (CTXR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.9459+0.0469 (+5.22%)
At close: 3:59PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Previous Close0.8990
Open0.9000
Bid0.9306 x 900
Ask0.9460 x 800
Day's Range0.9000 - 0.9500
52 Week Range0.4000 - 1.9700
Volume368,811
Avg. Volume740,249
Market Cap52.475M
Beta (5Y Monthly)1.33
PE Ratio (TTM)N/A
EPS (TTM)-0.5360
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Citius Pharmaceuticals to Present at Virtual Fall Investor Summit
    PR Newswire

    Citius Pharmaceuticals to Present at Virtual Fall Investor Summit

    Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company developing and commercializing critical care drug products, today announced that management will present at the Virtual Fall Investor Summit to be held virtually on November 16-18, 2020. Leonard Mazur, Chairman of Citius, will deliver a corporate overview of the Company on Monday, November 16, at 1:00 p.m. Eastern Time. Mr. Mazur will also conduct virtual one-on-one meetings with investors during the conference.

  • Citius Pharmaceuticals to Present at H.C. Wainwright 6th Annual Israel Conference
    PR Newswire

    Citius Pharmaceuticals to Present at H.C. Wainwright 6th Annual Israel Conference

    Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company developing and commercializing critical care drug products, today announced that it will present at the H.C. Wainwright 6th Annual Israel Conference to be held virtually on November 12, 2020. Myron Holubiak, Chief Executive Officer of Citius, will provide an update of the Company's products under development and provide an overview on Thursday, November 12, at 2:30 p.m. Eastern Time. Mr. Holubiak will also conduct virtual one-on-one meetings with investors during the conference.

  • Citius Pharmaceuticals Issues October 2020 Letter to Shareholders
    PR Newswire

    Citius Pharmaceuticals Issues October 2020 Letter to Shareholders

    Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (NASDAQ: CTXR), a specialty pharmaceutical company developing and commercializing critical care drug products, announced that it has issued an October 2020 Letter to Shareholders. The letter addresses recent updates on the Company's business and clinical developments and news for its pipeline of products.